Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 10,569 shares at $182.07 ($1.9M) on 2025-11-18, disclosed to the SEC on 2025-11-20.
Open-market sale of $1.9M JAZZ by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $181.66 | 69 | $13K | 0.7% |
| 2 | $182.07 | 5,250 | $956K | 49.7% |
| 3 | $182.07 | 5,250 | $956K | 49.7% |
| Total | $182.07 avg | 10,569 | $1.9M | 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |
| JAZZ | SELL | 2025-03-03 | $917K | — | Filing → |